ProRetina's Seed VC Round

ProRetina raised a round of funding on January 26, 2013. Investors include Caixa Capital Risc.

ProRetina develops a drug for the treatment of retinitis pigmentosa, a genetic disease that causes a gradual degeneration of the retina and eventually blindness for which no current effective treatmen…

Articles about ProRetina's Seed VC Round: